Boston Scientific Corporation

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 21:00:02 17/01/2025 GMT			5-day change	1st Jan Change
98.66 ^USD	+0.50%		+4.28%	+10.46%

10:31am	Analyst recommendations: Apple, On Holding, Amazon, Palo Alto Networks, Tesla...
01-17	Sector Update: Health Care Stocks Decline Late Afternoon	MT

Boston Scientific Corporation has entered into a definitive agreement to acquire Intera Oncology Inc.

November 24, 2024

Boston Scientific Corporation (NYSE:BSX) has entered into a definitive agreement to acquire Intera Oncology Inc. on November 25, 2024. Boston Scientific expects to complete the transaction in the first half of 2025, subject to closing conditions.

Latest news about Boston Scientific Corporation

Analyst recommendations: Apple, On Holding, Amazon, Palo Alto Networks, Tesla...	10:31am
Sector Update: Health Care Stocks Decline Late Afternoon	01-17	MT
Boston Scientific on Track to Be Highest Performing Medtech Firm, RBC Says	01-17	MT
Boston Scientific Corporation Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-13-2025 05:15 PM	01-14
Baird Adjusts Price Target on Boston Scientific $104 From $102, Keeps Outperform Rating	01-13	MT
Deutsche Bank Upgrades Boston Scientific to Buy From Hold, Raises Price Target to $108 From $87	01-10	MT
Bernstein Adjusts Price Target on Boston Scientific to $110 From $100, Keeps Outperform Rating	01-09	MT
Fed Meeting Minutes Leave Equities Mixed	01-08	MT
Equities Close Mixed After Labor Market Data, Fed Minutes	01-08	MT
Equities Largely Unchanged After Labor Market Data, Fed Governor Remarks	01-08	MT
Stocks in motion: Quantum computing stocks tumble after Nvidia's CEO comment	01-08
Sector Update: Health Care Stocks Rise Premarket Wednesday	01-08	MT
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday Ahead of FOMC Meeting Minutes	01-08	MT
Boston Scientific to Acquire Remaining Stake in Bolt Medical for $443 Million Plus Milestone Payments	01-08	MT
Boston Scientific to Buy Rest of Bolt Medical for $443 Million	01-08	DJ
Boston Scientific Corporation entered into an agreement to acquire remaining 74% stake in Bolt Medical, Inc.	01-07	CI
ETF contrarian betting: and above all, Health!	01-07
UBS Raises Price Target on Boston Scientific to $105 From $102, Keeps Buy Rating	01-06	MT
Evercore ISI Adjusts Price Target on Boston Scientific to $100 From $95	01-02	MT
Hawkish hints spook investors	12-19
FDA classifies recall of Boston Scientific catheters as 'most serious'	12-18	RE
Baird Raises Boston Scientific Price Target to $102 From $100, Maintains Outperform Rating	12-18	MT
Truist Securities Adjusts Price Target on Boston Scientific to $110 From $100, Keeps Buy Rating	12-18	MT
RBC Raises Price Target on Boston Scientific to $105 From $98, Keeps Outperform Rating	12-18	MT
Goldman Sachs Raises Price Target on Boston Scientific to $103 From $102, Maintains Buy Rating	12-16	MT

Chart Boston Scientific Corporation

Duration

Period

BSX: Dynamic Chart

Company Profile

Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.

Employees

48,000

Sector

Advanced Medical Equipment & Technology

Calendar

05/02/2025 - Q4 2024 Earnings Release

More about the company